China Pharma submits plan of compliance to NYSE American
The company was directed to submit a plan of compliance by July 15, 2022
The company was directed to submit a plan of compliance by July 15, 2022
She joins Enveda from Gilead Sciences
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
Submission seeks approval for the treatment of COVID-19 in both vaccinated and unvaccinated individuals at high risk
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
LoveDepot.com addresses this gap that is yawning in the market
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
Subscribe To Our Newsletter & Stay Updated